These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25267439)

  • 1. Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
    Michel L; Chesneau M; Manceau P; Genty A; Garcia A; Salou M; Elong Ngono A; Pallier A; Jacq-Foucher M; Lefrère F; Wiertlewski S; Soulillou JP; Degauque N; Laplaud DA; Brouard S
    Clin Immunol; 2014 Dec; 155(2):198-208. PubMed ID: 25267439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
    Lindner S; Dahlke K; Sontheimer K; Hagn M; Kaltenmeier C; Barth TF; Beyer T; Reister F; Fabricius D; Lotfi R; Lunov O; Nienhaus GU; Simmet T; Kreienberg R; Möller P; Schrezenmeier H; Jahrsdörfer B
    Cancer Res; 2013 Apr; 73(8):2468-79. PubMed ID: 23384943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B cells, helminths, and multiple sclerosis.
    Correale J; Equiza TR
    Methods Mol Biol; 2014; 1190():257-69. PubMed ID: 25015286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids.
    de Andrés C; Tejera-Alhambra M; Alonso B; Valor L; Teijeiro R; Ramos-Medina R; Mateos D; Faure F; Sánchez-Ramón S
    J Neuroimmunol; 2014 May; 270(1-2):37-44. PubMed ID: 24662004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
    Feger U; Luther C; Poeschel S; Melms A; Tolosa E; Wiendl H
    Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
    Haas J; Hug A; Viehöver A; Fritzsching B; Falk CS; Filser A; Vetter T; Milkova L; Korporal M; Fritz B; Storch-Hagenlocher B; Krammer PH; Suri-Payer E; Wildemann B
    Eur J Immunol; 2005 Nov; 35(11):3343-52. PubMed ID: 16206232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
    Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
    Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
    Blumenfeld S; Staun-Ram E; Miller A
    J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.
    van der Vlugt LE; Mlejnek E; Ozir-Fazalalikhan A; Janssen Bonas M; Dijksman TR; Labuda LA; Schot R; Guigas B; Möller GM; Hiemstra PS; Yazdanbakhsh M; Smits HH
    Clin Exp Allergy; 2014 Apr; 44(4):517-28. PubMed ID: 24261983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low DPP4 expression and activity in multiple sclerosis.
    Tejera-Alhambra M; Casrouge A; de Andrés C; Ramos-Medina R; Alonso B; Vega J; Albert ML; Sánchez-Ramón S
    Clin Immunol; 2014 Feb; 150(2):170-83. PubMed ID: 24412911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
    Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
    Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
    Sánchez-Ramón S; Navarro A J; Aristimuño C; Rodríguez-Mahou M; Bellón JM; Fernández-Cruz E; de Andrés C
    Immunol Lett; 2005 Jan; 96(2):195-201. PubMed ID: 15585323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.